Targeting BMI1 enhances cell adhesion to inhibit colorectal cancer progression and improve the efficacy of cetuximab

Coverage, in order

1. 14h ago
   Research Square obscure study

   Targeting BMI1 enhances cell adhesion to inhibit colorectal cancer progression and improve the efficacy of cetuximab

   Colorectal cancer (CRC) is a common malignant tumor with poor prognosis, urgently requiring new biomarkers and therapeutic targets. This study investigated the role of BMI1 in the progression of colorectal cancer and its regulatory mechanisms, as well as evaluated whether targeting BMI1 can enhance…

Alivewire groups outlets reporting the same story. Each headline links to the outlet that wrote it; nothing is republished here.